Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Experts anticipate an approval filing could occur in late 2026 or 2027 following the conclusion of Phase 3 trials
Clinical trials of GLP-1 drugs have found they can lower inflammation, decrease the risk of cardiovascular and kidney disease and may help cut cravings for alcohol and tobacco
Therefore, this medication should only be administered under the supervision of a healthcare professional
In parallel, there is growing focus on small molecule GLP-1R agonists , which have the potential to be administered orally, produced more cost-effectively, and offer improved stability and pharmacokinetic profiles
US$ 26.29
US$ 29.91
US$ 24.65
US$ 20.46
US$ 27.13
US$ 20.18
